Cansartan-Mepha plus 8/12.5, Tabletten - 98 Tablette(n) Swissmedic Key 61215006 Registration Holder Mepha Pharma AG Name Cansartan-Mepha plus 8/12.5, Tabletten Date of registration 24.01.2011 Original/Generic Generic Introduction of Sequence 24.01.2011 ATC-Classification Candesartan and Diuretics (C09DA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 02.07.20. Show package size 98 Tablette(n) Index Therapeuticus (Swissmedic) 02.07.20. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information CI Ex-factory-Price 23.77 Limitation No Deductible 10 % Consumer price 42.35 Feedback FB GTIN 7680612150060 Medication Code Synthetika Pharmacode 5431360 Disponibility
Composition candesartanum cilexetilum 8.00 mg, hydrochlorothiazidum 12.50 mg, maydis amylum, lactosum monohydricum 117.30 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.43 mg, magnesii stearas, pro compresso. Packungsbestandteile Galenic Form Tablets Active Agent Dose Candesartanum Cilexetil 8 mg Hydrochlorothiazide 12.5 mg
BAG: Active Agent Dose Candesartanum Cilexetil 8 mg Hydrochlorothiazide 12.5 mg
Inactive agents Dose Carmellosum Natricum Conexum Hydroxypropylcellulosum Lactose Monohydrate 117.3 mg Magnesii Stearas Maydis Amylum Pro Compresso Triethylis Citras
Source Data was imported : 12.05.2021
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
